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Abstract: In this study, combination antimicrobial therapy, due to its higher potential against resistant bacteria, was evaluated for
the inhibition of multidrug-resistant E. coli strains. The influence of pH as an environmental variable on the activity of antimicrobial
combinations was evaluated by calculating the factional concentration indexes at pH values 5.0, 6.0, 7.3, and 8.0.
The highest synergistic activity rates of ceftriaxone + colistin, danofloxacin + colistin, danofloxacin + ceftiofur, and ceftiofur +
gentamicin combinations were 50%, 33%, 100%, and 50%, respectively measured at ≥7.3 pH. The lowest synergistic activity rates for all
combinations were observed at the acidic pH values of 5.0 and 6.0. The results of this study clearly demonstrated that acidic pH of the
medium impaired the activity of the antimicrobial combinations. Although ceftriaxone and ceftiofur exert optimal activity at acidic pH
values, the synergistic activity of the co-used drugs reached its highest level at pH ≥7.3.
Key words: pH, antimicrobial combination, E. coli, resistance, animals

1. Introduction
Multidrug-resistant (MDR) bacteria are significant
health problems globally. MDR is a commonly observed
phenomenon in Escherichia coli (E. coli) strains and
there are various genes encoding resistance against
many compounds from various classes of antimicrobials.
Mechanisms of resistance include enzymatic degradation
of the compound, modification of the target, discharge of
the antimicrobial from the bacteria, and prevention of the
entrance of antimicrobial into the bacterial cell. The couse of antimicrobials reduces the possibility of resistance,
increases efficacy, and provides broad-spectrum activity [1–
4]. The activity of antimicrobials such as fluoroquinolones,
aminoglycosides, and macrolides is influenced by the pH
of the bacterial medium or body fluids [5,6]. The ionized
fraction of a compound is not able to efficiently penetrate
the bacterial membrane; hence, minimum inhibitory
concentrations (MICs) are elevated. At physiological pH,
most fluoroquinolones are in their least ionized state,
allowing a major fraction of the molecules to freely enter
bacterial cells [7]. Low pH values markedly decrease
activity of aminoglycosides. In contrast to this, acidic pH
values almost linearly increase the activity of β-lactam
antibiotics [6]. There is very limited data on the activity

of colistin (CST) at various pH values. Burian et al. [8]
showed that the activity of CST was gradually reduced by
lowering the pH. Current data, although limited, are at
a satisfying enough level to estimate the possible effects
of pH on the activity of some antimicrobials alone. In
addition, there are only a few scientific reports on the
pH–antimicrobial activity relationship for combinations
used in human medicine [5,9]. In contrast, there are no
scientific studies on the activity of co-used antimicrobials
being pH-dependent in the veterinary field. Therefore,
the objective of this study was to investigate impact of
pH on the synergistic activity of co-used antimicrobials:
ceftriaxone (CRO) + CST, danofloxacin (DAN) + CST,
DAN + ceftiofur (CEF), CEF + gentamicin (GEN). Six E.
coli strains having different resistance profiles were utilized
as subjects in this study.
2. Materials and methods
For isolation of E. coli, the swabs were directly inoculated
onto specific agars and incubated in aerobic conditions.
Candidate E. coli colonies were identified by API 20 E,
and results evaluated by the API-Web system. Broth
microdilution testing was performed to determine the
MICs of the antimicrobials according to the guidelines of
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Clinical Laboratory Standards Institute [10]. MICs were
defined as the minimum concentration of antibiotic that
inhibited growth of the organism. Random amplified
polymorphic DNA (RAPD) analysis was used to determine
the genetic relatedness of E. coli isolates from animals.
Six representative E. coli isolates from cattle were chosen
from different RAPD patterns based on their resistance
profiles. The activities of CRO + CST, DAN + CST, DAN
+ CEF, and CEF + GEN were tested with the fractional
inhibitory concentration (FIC) method at pH values of
5.0, 6.0, 7.3, and 8.0. Mueller–Hinton broth medium was
used for FIC, and the pH values were adjusted using a pH
meter by the addition of sterile 1N HCl and 1N NaOH
solutions [7,11,12]. The inoculum was 105 CFU per well
and the microplates were incubated at 37 °C. FICs were
evaluated after 16–18 h for E. coli isolates. FICs (MIC of
antibiotic in combination)/(MIC antibiotic alone) of the
combinations were determined using the checkerboard
method and summed to give åFIC indices, which were
interpreted as follows: FICI ≤ 0.5 = synergy; FICI > 4.0 =
antagonism; FICI > 0.5–4 = indifference.
3. Results
The 6 E. coli isolates chosen for the study were from 5
different epidemiological origins according to their RAPD
patterns. RAPD patterns and the antimicrobial resistance
profiles of the E. coli strains are given in the Table. The
FICIs of the CRO + CST combination were calculated at
different pH values (Figure 1). FICIs ranged from 0.28 to
12 for pH 5.0; from 0.5 to 12 for pH 6.0; from 0.37 to 12 for
pH 7.3; from 0.37 to 12 for pH 8.0. Synergistic activity at
pH values of 5.0, 6.0, 7.3, and 8.0 was observed for 2/6, 2/6,
2/6, and 3/6 of the E. coli isolates, respectively. Antagonism
was detected for 3 or 4 of the E. coli isolates at each pH

value tested. FICIs of the DAN + CST combination ranged
from 0.63 to 8 for pH 5.0; from 4.03 to 8 for pH 7.3; from
0.28 to 8 for pH 8.0 (Figure 2). FICI was 8 for all E. coli
isolates at pH 6. Synergistic activity was observed for 2/6
of the E. coli isolates at pH 8. FICIs of the DAN + CEF
combination ranged from 0.38 to 8 for pH 5.0; from 0.16 to
8 for pH 6.0; from 0.03 to 1.03 for pH 7.3; from 0.03 to 0.3
for pH 8.0 (Figure 3). Synergistic activity at pH values of
5.0, 6.0, 7.3, and 8.0 was observed for 2/6, 4/6, 5/6, and 6/6
of E. coli isolates, respectively. Antagonism was detected
for 3/6 of E. coli isolates at pH 5.0 and for 1/6 for pH 6.0.
FICIs of the CEF + GEN combination ranged from 0.03 to
8 for pH 5.0; from 0.03 to 8 for pH 6.0; from 0.03 to 1.13 for
pH 7.3; from 0.03 to 1.5 for pH 8.0 (Figure 4). Synergistic
activity at pH levels of 5.0, 6.0, 7.3, and 8.0 was observed
for 2/6, 2/6, 4/6, and 3/6 of E. coli isolates, respectively. The
highest synergism rate was observed at pH 7.3.
4. Discussion
Although there are a sufficient number of reports about
the influence of pH on the activity of antimicrobials used
alone, there is no data on pH-dependent activity of co-used
antimicrobials against resistant strains in the veterinary
field. The pH at the site of infection is reduced to below
the neutral value due to bacterial activity and host immune
response [13]. pH-dependent activity is a consequence of the
changes in known pharmacokinetics/pharmacodynamics
of the compound arising from environmental drivers. The
activity of fluoroquinolones is affected by acidification
of the medium [11], as the high concentrations of H+
ions at low pH values change the electric charge of the
fluoroquinolone molecule and thus reduce the penetration
of the drug to the bacterial cell [8]. However, finafloxacin
exerts stronger activity at slightly acidic pH values while

Table. RAPD patterns and resistance profiles of E. coli strains.
Isolate ID

RAPD
Patterns

Resistance Profiles

E175

L

sulfamethoxazole

E222

T

nalidixic acid, ciprofloxacin, sulfamethoxazole, trimethoprim, tetracycline, oxytetracycline,
chloramphenicol

E245

S

nalidixic acid, ciprofloxacin, orbifloxacin, gatifloxacin, ampicillin, ceftiofur, tetracycline, oxytetracycline,
erythromycin, chloramphenicol

E246

S

nalidixic acid, gatifloxacin, ampicillin, trimethoprim, tetracycline, oxytetracycline, chloramphenicol,
colistin

E269

E

nalidixic acid, sulfamethoxazole, trimethoprim, tetracycline, oxytetracycline, colistin

E306

C

nalidixic acid, ciprofloxacin, orbifloxacin, ampicillin, trimethoprim, tetracycline, oxytetracycline,
erythromycin, chloramphenicol

RAPD: Random amplified polymorphic DNA.
L, T, S, E, and C: Each RAPD pattern.
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CRO: Ceftriaxone, CST: Colistin

Figure 1. Fractional inhibitory indexes of the ceftriaxone + colistin combination
against resistant E. coli strains.
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Figure 2. Fractional inhibitory indexes of the danofloxacin + colistin
combination against resistant E. coli strains.
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Figure 3. Fractional inhibitory indexes of the danofloxacin + ceftiofur
combination against resistant E. coli strains.

MICs of moxifloxacin, levofloxacin, and ciprofloxacin have
2- to 8-fold increases at pH 5.8 and 6.2 [12]. Lowering
the pH of the medium from pH 7.4 to pH 5.5 decreases
the MICs up to 512-fold for widely used cephalosporins

such cephalexin, cefuroxime, cefoxitin, ceftriaxone, and
ceftobiprole. The activity of trimethoprim alone and the
trimethoprim–sulfamethoxazole combination significantly
increases at higher pH values. However, this combination
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Figure 4. Fractional inhibitory indexes of the ceftiofur + gentamicin
combination against resistant E. coli strains.

results in different activity against various strains [14].
Some bacterial strains are more susceptible to gentamicin
at pH values above 7, while the same strains are resistant
to this antibiotic at pH values below 6 [14]. In this study,
a remarkable increase in the antimicrobial activity was
observed for DAN + CEF. Synergistic activity increased
at high pH values (7.3, 8.0) against all strains except for E.
coli E222 at pH 7.3. As has been reported previously, the
activity of DAN and CEF alone increases at high pH and
low pH values, respectively. The pH levels at which DAN
+ CEF exerted maximum synergism were pH 7.3 and 8.0.
Similarly, the activity of the CEF + GEN combination was
increased at pH levels 7.3 and 8.0. Higher pH values (7.3 and
8.0) decreased FICIs up to 10-fold, and synergistic activity
increased 2-fold. Acidic pH values markedly reduced the
activity of gentamicin and increased the activity of β-lactam
antibiotics [6,14]. In this study, CEF did not cause a decrease
in the synergistic potential of either combination, while
β-lactam antibiotics exerted optimum activity at acidic pH
values. CRO + CST and DAN + CST combinations showed
different activity at low and high pH values. The CRO + CST

combination exerted more synergistic activity against E. coli
strains than DAN + CST. Synergistic activity was observed
against 3/6 E. coli isolates at pH values 7.3 and 8.0. Burian et
al. found that CST exerted the highest activity against E. coli
at pH values 7.0 and 8.0 [8]. The lowest synergistic activity
was observed for the DAN + CST combination against only
2/6 E. coli isolates at pH 8.0. It can be concluded that the
pH of the medium impairs the activity of the antimicrobial
combinations. Although CRO and CEF are β-lactam
antibiotics exerting optimal activity at acidic pH values, the
synergistic activity of the co-used drugs reaches its highest
level at pH values ≥7.3.
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